SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-21-013642
Filing Date
2021-07-19
Accepted
2021-07-19 16:11:33
Documents
1
Period of Report
2021-07-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 4214
  Complete submission text file 0001567619-21-013642.txt   5612
Mailing Address 329 OYSTER POINT BLVD., 3RD FLOOR SOUTH SAN FRANCISCO CA 904080
Business Address 329 OYSTER POINT BLVD., 3RD FLOOR SOUTH SAN FRANCISCO CA 904080 650 325 5156
Imago BioSciences, Inc. (Issuer) CIK: 0001623715 (see all company filings)

IRS No.: 454915810 | State of Incorp.: DE | Fiscal Year End: 1214
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ZENTALIS PHARMACEUTICALS, LLC 530 SEVENTH AVENUE, SUITE 2201 NEW YORK NY 10018
Business Address
Kariuki Enoch (Reporting) CIK: 0001843119 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40604 | Film No.: 211098026